Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

2.08
Delayed Data
As of 3:21pm ET
 -0.05 / -2.35%
Today’s Change
1.60
Today|||52-Week Range
24.00
-5.68%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close2.13
Today’s open2.15
Day’s range2.05 - 2.17
Volume319,293
Average volume (3 months)1,966,621
Market cap$76.1M
Data as of 3:21pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)-34.73%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.49

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.61+0.76%
PRTKParatek Pharmaceutic...+0.02+0.14%
AMPHAmphastar Pharmaceut...+0.53+2.82%
RETAReata Pharmaceutical...+0.88+3.05%
Data as of 3:36pm ET, 01/17/2018

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$0.93
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Jay P. Shepard
Chief Medical Officer, Head-Clinical &
Medical
Robert Gut
Corporate headquarters
Menlo Park, California

Forecasts